Novel Digital Endpoint Solutions for Early and Mid-Phase Development Webinar Replay
Watch this webinar to hear Clario’s scientific and operational experts along with Tina Soulis, Founder and Director of Alithia Life Sciences, as they focus on a regional perspective from Australia’s early-phase clinical trial ecosystem. Together, they’ll explore how digital endpoints, including eCOA, medical imaging and cardiac testing, can be implemented early in development to generate stronger evidence, reduce variability and support regulatory engagement.
In this on demand webinar, you will gain insight into:
- Principles for selecting and validating digital endpoints in early and mid-phase studies: what makes an endpoint scientifically robust, feasible and appropriate for early phase development
- How early-phase studies are used to refine endpoints and assess feasibility: using Phase I/II to test, adjust and de-risk endpoints before late-phase commitment
- Operational considerations for implementing digital endpoints across sites and CROs, including site readiness, training, data quality and managing added complexity
- Designing endpoints for continuity from early development into Phase III: how to minimize rework by building for scalability, reproducibility and regulatory acceptance
- The role of imaging and patient-reported outcomes in early oncology development: when and why these measures add value for dose optimization, safety and early efficacy signaling
